Guggenheim analyst Vamil Divan maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target of ...

Dwayne "The Rock" Johnson's contract includes a "no-lose" clause that ensures his characters always emerge victorious in ...

Elon Musk has taken control of government employees’ private data by having his cronies illegally install a commercial server ...

Darren Beattie, a conservative journalist who was fired from the Trump administration in 2018 after revelations about his ...

In a Saturday opinion piece, The Wall Street Journal editorial board condemned Trump's trade plans, arguing that his 25 ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $166 from $162 and keeps a Neutral rating on the ...

Guggenheim maintained a Neutral rating on Johnson & Johnson (NYSE:JNJ) but increased the stock's price target from $162.00 to $166.00. The adjustment follows the release of the company's ...

Even in war, branding applies. Israel and Hamas are engaged in a parallel battle of optics despite a ceasefire that took ...

Follow along to find out who wins a Grammy on music's biggest night. Who will scoop up the most gramophone trophies on music’s biggest night?

The purpose of this call for proposals is to support projects that seed new and unconventional ideas that could radically advance health equity for generations to come.